104 related articles for article (PubMed ID: 23991840)
1. Angiogenesis.
Huang LC; Hsu KH; Hueng DY
J Neurosurg; 2013 Nov; 119(5):1352. PubMed ID: 23991840
[No Abstract] [Full Text] [Related]
2. Response.
Yener U; Avsar T; Akgün E; Şeker A; Bayri Y; Kılıç T
J Neurosurg; 2013 Nov; 119(5):1353. PubMed ID: 24344455
[No Abstract] [Full Text] [Related]
3. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
Yener U; Avsar T; Akgün E; Şeker A; Bayri Y; Kılıç T
J Neurosurg; 2012 Oct; 117(4):697-704. PubMed ID: 22900848
[TBL] [Abstract][Full Text] [Related]
4. Hypervascular acoustic neuroma.
LeMay DR; Sun JK; Fishback D; Locke GE; Giannotta SL
Neurol Res; 1998 Dec; 20(8):748-50. PubMed ID: 9864742
[TBL] [Abstract][Full Text] [Related]
5. [Targeted anticancer drugs and their development].
Kervinen J; Gahmberg CG
Duodecim; 2004; 120(19):2323-30. PubMed ID: 15565985
[No Abstract] [Full Text] [Related]
6. Neurofibromatosis type 2.
Sathornsumetee S; DesJardins A; Reardon DA; Rich JN; Vredenburgh JJ
Neurology; 2007 Mar; 68(13):E14. PubMed ID: 17389295
[No Abstract] [Full Text] [Related]
7. Anti-VEGF treatment improves neurological function in tumors of the nervous system.
Zhang N; Chen J; Ferraro GB; Wu L; Datta M; Jain RK; Plotkin SR; Stemmer-Rachamimov A; Xu L
Exp Neurol; 2018 Jan; 299(Pt B):326-333. PubMed ID: 28911884
[TBL] [Abstract][Full Text] [Related]
8. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
Özcetin A; Aigner A; Bakowsky U
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
[TBL] [Abstract][Full Text] [Related]
9. Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.
Sumida T; Kitadai Y; Shinagawa K; Tanaka M; Kodama M; Ohnishi M; Ohara E; Tanaka S; Yasui W; Chayama K
Int J Cancer; 2011 May; 128(9):2050-62. PubMed ID: 21387285
[TBL] [Abstract][Full Text] [Related]
10. On the offensive.
Abbott A
Nature; 2002 Apr; 416(6880):470-4. PubMed ID: 11932714
[No Abstract] [Full Text] [Related]
11. [Molecular treatment of cancer. Imatinib].
Lopez M
Clin Ter; 2001; 152(6):399-407. PubMed ID: 11865537
[No Abstract] [Full Text] [Related]
12. CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.
Chacón M; Roca E; Huertas E; Loria FS; Domenechini E
J Clin Oncol; 2005 Mar; 23(7):1580-2. PubMed ID: 15735135
[No Abstract] [Full Text] [Related]
13. FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis.
Gilliland G; Cools J; Stover EH; Wlodarska I; Marynen P
Hematol J; 2004; 5 Suppl 3():S133-7. PubMed ID: 15190295
[No Abstract] [Full Text] [Related]
14. Potential role of imatinib mesylate (Gleevec, STI-571) in the treatment of vestibular schwannoma.
Altuna X; Lopez JP; Yu MA; Arandazi MJ; Harris JP; Wang-Rodriguez J; An Y; Dobrow R; Doherty JK; Ongkeko WM
Otol Neurotol; 2011 Jan; 32(1):163-70. PubMed ID: 21157293
[TBL] [Abstract][Full Text] [Related]
15. New Gleevec treatment approved.
FDA Consum; 2002; 36(2):6. PubMed ID: 11989477
[No Abstract] [Full Text] [Related]
16. Cancer treatment. New drugs, new hope.
Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
[No Abstract] [Full Text] [Related]
17. [Tyrosine kinase inhibitors in tumor therapy--part 1. Molecular and genetic fundamentals].
Grimm CF; Blum HE; Geissler M
Dtsch Med Wochenschr; 2005 May; 130(21):1318-22. PubMed ID: 15902620
[No Abstract] [Full Text] [Related]
18. Progressive thoughts about progressive disease.
Shah NP
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5229-31. PubMed ID: 17875748
[No Abstract] [Full Text] [Related]
19. Imatinib mesylate for melanoma: will a new target be revealed?
Grossman D
J Invest Dermatol; 2004 Dec; 123(6):xi-xiii. PubMed ID: 15610499
[No Abstract] [Full Text] [Related]
20. [The tyrosine kinase antagonist imatinib mesylate].
Heinzl S
Med Monatsschr Pharm; 2002 Jan; 25(1):4-7. PubMed ID: 11826665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
